01.02.2018 • NewsElaine BurridgeKanekaHenkel

Kaneka Aerospace Takes Henkel’s Composites

Kaneka Aerospace, a wholly owned subsidiary of Kaneka Americas Holding, has...
Kaneka Aerospace, a wholly owned subsidiary of Kaneka Americas Holding, has acquired Henkel’s benzoxazine-based high-performance composites business for an undisclosed sum (c) Henkel

Kaneka Aerospace, a wholly owned subsidiary of Kaneka Americas Holding, has acquired Henkel’s benzoxazine-based high-performance composites business for an undisclosed sum.

The deal gives Kaneka products such as benzoxazine-based prepregs, film adhesives and infusion resins, several of which have been qualified in the aviation market. Kaneka said the addition of these products and technologies to its portfolio would further enhance its ability to penetrate the aerospace sector.

The aerospace subsidiary was formed last September following the acquisition of California-based Applied Poleramic for around $15 million. The purchase gave Kaneka access to advanced formulated resins technology used in high-performance composites, allowing it to enter the “promising” aerospace sector.

At the time of buying Applied Poleramic, Kaneka said there was rapid growth for high-performance composites in demanding aerospace applications such as engines, hot aircraft areas, rockets and launch vehicles, and predicted the sector would grow more than 10% per year within the next 10 years, or exceed $2 billion in market value.

The company added that it would continue to seek M&A and partnership opportunities for further growth with the aim of achieving more than $200 million in sales by 2025 in high-performance composites for aerospace applications.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.